Circadian aspects in the pathophysiology of the restless legs syndrome

Sleep Medicine

Volumn 3, Issue SUPPL. 1, 2002, Pages

  Garcia Borreguero, D ^a   Larrosa, O ^a   de la Llave, Y ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Circadian rhythm; Dopamine; Periodic leg movement; Sleep; Tetrahydrobiopterin

Indexed keywords

LEVODOPA;

CIRCADIAN RHYTHM; CONTROLLED STUDY; CORE TEMPERATURE; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; EVIDENCE BASED MEDICINE; HOMEOSTASIS; HUMAN; MOTOR DYSFUNCTION; NEUROENDOCRINOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SENSORY DYSFUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; WAKEFULNESS;

EID: 0036865257     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(02)00143-0     Document Type: Article

References (57)

1. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000;54:1064-1068.
2. Phillips B, Young T, Finn L, Asher K, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
3. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
4. Picchietti DL, Underwood DJ, Farris WA, Walters AS, et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 1999;14:1000-1007.
5. Picchietti DL, England SJ, Walters AS, Willis K, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998;13:588-594.
6. Gibb WR, Lees AJ. The restless legs syndrome. Postgrad Med J 1986;62:329-333.
7. Walters AS, Hening WA, Chokroverty S. Review and videotape recognition of idiopathic restless legs syndrome. Mov Disord 1991;6:105-110.
8. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-147.
9. Pelletier G, Lorrain D, Montplaisir J. Sensory and motor components of the restless legs syndrome. Neurology 1992;42:1663-1666.
10. Pollmacher T, Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep 1993;16:572-577.
11. Trenkwalder C, Walters AS, Hening W. Periodic limb movements and restless legs syndrome. Neurol Clin 1996;14:629-650.
12. Chaudhuri KR, Appiah-Kubi LS, Trenkwalder C. Restless legs syndrome. J Neurol Neurosurg Psychiatry 2001;71:143-146.
13. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000;62:623-628.
14. Hening W, Allen R, Earley C, Kushida C, et al. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999;22:970-999.
15. Chesson Jr AL, Wise M, Davila D, Johnson S, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999;22:961-968.
16. Ekbom KA. Restless legs syndrome. Neurology 1960;10:868-873.
17. 11C-raclopride PET studies. Neurology 1999;23:932-937.
18. Ruottinen HM, Partinen M, Hublin C, Bergman J, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000;54:502-504.
19. Staedt J, Stoppe G, Kogler A, Riemann H, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 1995;245:8-10.
20. Trenkwalder C, Walters AS, Hening WA, Chokroverty S, et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999;14:141-145.
21. Earley CJ, Hyland K, Allen RP. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord 2001;16:144-149.
22. Desautels A, Turecki G, Montplaisir J, Ftouhi-Paquin N, et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology 2001;57:1304-1306.
23. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15:154-158.
24. Hening WA, Walters AS, Wagner M, Rosen R, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 1999;22:901-912.
25. Trenkwalder C, Hening WA, Walters AS, Campbell SS, et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord 1999;14:102-110.
26. Krauchi K, Wirz-Justice A. Circadian clues to sleep onset mechanisms. Neuropsychopharmacology 2001;25(Suppl 5):S92-S96.
27. Montplaisir J, Boucher S, Nicolas A, Lesperance P, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998;13:324-329.
28. Lewy AJ. The dim light melatonin onset, melatonin assays and biological rhythm research in humans. Biol Signals Recept 1999;8:79-83.
29. Montplaisir J, Boucher S, Gosselin A, Poirier G, et al. The restless legs syndrome: evening vs. morning restlessness [abstract]. Sleep Res 1995;24:302.
30. Glynn CJ, Lloyd JW, Folkard S. The diurnal variation in perception of pain. Proc R Soc Med 1976;69:369-373.
31. Perlow MJ, Gordon EK, Ebert ME, Hofman HJ, et al. The circadian variation in dopamine metabolism in the subhuman primate. J Neurochem 1977;28:381-1383.
32. Shade R, Vick K, Ott T, Sohr R, et al. Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats -influence of dopaminergic stimulation. Chronobiol Int 1995;12:87-99.
33. Sowers JR, Vlachakis N. Circadian variation in dopamine levels in man. J Endocrinol Invest 1984;7:341-345.
34. Doran AR, Labarca R, Wolkowitz OM, Roy A, et al. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia. Arch Gen Psychiatry 1990;47:558-563.
35. Nir I, Haque R, Iuvone PM. Diurnal metabolism of dopamine in the mouse retina. Brain Res 2000;870:118-125.
36. Andretic R, Hirsh J. Circadian modulation of dopamine receptor responsiveness in Drosophila melanogaster. Proc Natl Acad Sci USA 2000;97:1873-1878.
37. Ahlers L, Pastorova B, Solar P, Ahlersova E. Daily rhythm in rat pineal catecholamines. Physiol Res 1999;48:231-234.
38. Lal S, Tesfaye Y, Thavundayil JX, Skorzewska A, et al. Effect of time-of-day on the yawning response to apomorphine in normal subjects. Neuropsychobiology 2000;41:178-180.
39. Kawano Y, Kawasaki T, Kawazoe N, Abe I, et al. Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects. Nephron 1990;55:277-282.
40. Hagan MM, Havel PJ, Seeley RJ, Woods SC, et al. Cerebrospinal fluid and plasma leptin measurement: covariability with dopamine and cortisol in fasting humans. J Clin Endocrinol Metab 1999;84:3579-3585.
41. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. New York: Oxford University Press, 1991.
42. Segawa M, Hosaka A, Miyagawa F, Nomura Y, et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976;14:215-233.
43. Nygaard TG. Dopa-responsive dystonia: delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993;60:577-585.
44. Ichinose H, Ohye T, Takahashi E. Hereditary progressive dystonia with marked diurnal fuctuation caused by mutations in the GTP cyclohydrolase gene. Nat Genet 1994;8:236-242.
45. Mandel AJ, Bullard WP, Yellin JB, Russo PV. The influence of damphetamine on rat brain striatal reduced biopterin concentration. J Pharmacol Exp Ther 1980;213:569-574.
46. Earley CJ, Connor JR, Beard JL, Malecki EA, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700.
47. Scales WE, Vander AJ, Brown MB, Kluger MJ. Human circadian rhythms in temperature, trace metals, and blood variables. J Appl Physiol 1988;65:1840-1846.
48. Friess E, Kuempfel T, Winkelmann J, Schmid D, et al. Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. Arch Neurol 2001;58:241-246.
49. Kostic VS, Susic V, Przedborski S, Sternic N. Sleep EEG in depressed and nordepressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 1991;3:176-179.
50. Llau ME, Durrieu G, Tran MA, Senard JM, et al. A study of dopaminergic sensitivity in Parkinson's disease: comparison in 'de novo' and levodopa-treated patients. Clin Neuropharmacol 1996;19:420-427.
51. Fabbrini G, Braun A, Mouradian MM, Tamminga CA, et al. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man. J Neural Transm 1988;71:159-163.
52. Chihara K, Kato Y, Maeda K, Ohgo S, Imura H. Suppressive effect of L-dopa on human prolactin release during sleep. Acta Endocrinol (Copenh) 1976;81:19-27.
53. Benker G, Jaspers C, Hausler G, Reinwein D. Control of prolactin secretion. Klin Wochenschr 1990;68:1157-1167.
54. Martin JB. Neural regulation of growth hormone secretion. Med Clin North Am 1978;62:327-336.
55. Muller EE. Nervous control of growth hormone secretion. Neuroendocrinology 1973;11:338-369.
56. Garcia-Borreguero D, Larrosa O, Saiz T, et al. Circadian variation in neuroendocrine response to the administration of L-dopa in patients with restless legs syndrome: a pilot study [abstract]. Sleep 2001;24:A2.
57. Garcia-Borreguero D, Larrosa O, Saiz T, et al. Circadian variation in neuroendocrine response to the administration of L-dopa in patients with restless legs syndrome [abstract]. Acta Fisiol (World Congress WFSRS) 2001;7:219.